Draft Program
Program Co-Chairs
Demissie Alemayehu, Pfizer & David Madigan, Columbia
7:30 AM – 8:25 AM
- Registration and Breakfast
8:25 AM – 8:30 AM
- Welcome Address
- David Madigan, Ph.D., Columbia University
8:30 Am – 9:00 AM
- Opening Plenary Session (Chair D. Madigan)
- Kannan Natarajan, Ph.D., Pfizer Inc.
9:00 AM – 10:00 Am
- Keynote Address I (Chair K. Natarajan)
- Amy P. Abernethy, MD, Ph.D
- US Food and Drug Administration (FDA)
10:00 AM – 10:30 AM
- Break
10:30 AM – 11:00 AM
- Plenary Session I (Chair, D. Alemayehu, Pfizer Inc)
- “ML and AI in Clinical Development and Statistical Innovation in AbbVie.”
- Wang Li, Ph.D., AbbVie
- Lawrence Carin, Ph.D. Duke University
11:00 – 11:30
- Break
11:30 – 12:00
12:00 – 12:30
- Plenary Session II (Chair TBD)
- “Artificial Intelligence in Pharmaceutical R&D at AstraZeneca.” Faisal Khan, AstraZeneca
- Noémie Elhadad, Ph.D., Columbia University
12:30 -1:00
- Lunch
1:00 – 2:00
- Keynote Address II (Chair D. Madigan)
- Mihaela van der Schaar
- University of Cambridge and UCLA
2:00 – 2:30
- Break
2:30 – 3:00
- Plenary Session III (Chair TBD)
- Adler Perotte, Columbia University
- Jesse A. Berlin, Johnson & Johnson
3:00 – 3:15
- Break
3:15 – 4:50
- Panel Discussion: “Ethical Issues with AI in Clinical Drug Development”
- (Moderator, Jeannette M. Wing, Ph.D., Columbia University)
- FDA
- TBD
- TBD
4:50 – 5:00
- Closing Remarks and wrap-up
- Demissie Alemayehu, Ph.D., Pfizer Inc